0.00Open0.00Pre Close0 Volume0 Open Interest66.00Strike Price0.00Turnover146.37%IV-13.62%PremiumDec 20, 2024Expiry Date10.41Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8550Delta0.0200Gamma6.73Leverage Ratio-0.3473Theta0.0056Rho5.76Eff Leverage0.0178Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet